About MiCoBioMed
MiCoBioMed is a company based in Anseong (South Korea) founded in 2009.. MiCoBioMed offers products and services including Veri-Q PCR 316, Veri-Q PREP M16, Veri-Q COVID-19 Ag Rapid Test, Veri-Q COVID-19 IgG/IgM Rapid Test, and Opti96 ELISA Plate. MiCoBioMed operates in a competitive market with competitors including Jana Care, Telcare, Intuity Medical, Hygieia and Ascensia, among others.
- Headquarter Anseong, South Korea
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Mico Biomed Co., Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of MiCoBioMed
MiCoBioMed is a publicly listed company on the KRX with ticker symbol 214610 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of MiCoBioMed
MiCoBioMed offers a comprehensive portfolio of products and services, including Veri-Q PCR 316, Veri-Q PREP M16, Veri-Q COVID-19 Ag Rapid Test, Veri-Q COVID-19 IgG/IgM Rapid Test, and Opti96 ELISA Plate. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Real-time PCR system for quick gene detection and results
Device for extracting nucleic acid using tubes efficiently
Rapid test for detecting SARS-CoV-2 antigens in samples
Kit for simultaneous detection of IgG and IgM antibodies
Platform for rapid ELISA diagnostics using microfluidics
Device for biochemical testing and analysis purposes
Funding Insights of MiCoBioMed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by MiCoBioMed
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MiCoBioMed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Micobiomed Comparisons
Competitors of MiCoBioMed
MiCoBioMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jana Care, Telcare, Intuity Medical, Hygieia and Ascensia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Mobile-based diagnostics for diabetes prevention and management are provided.
|
|
| domain | founded_year | HQ Location |
Diabetes is managed via cellular technology and social networking.
|
|
| domain | founded_year | HQ Location |
An all-in-one blood glucose monitoring system is developed and offered.
|
|
| domain | founded_year | HQ Location |
Insulin dosage guidance for diabetes is provided via handheld devices.
|
|
| domain | founded_year | HQ Location |
Provides blood glucose monitoring systems and diabetes care solutions worldwide.
|
|
| domain | founded_year | HQ Location |
Manufacturer and Global seller of Blood glucose monitoring systems
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Micobiomed
Frequently Asked Questions about MiCoBioMed
When was MiCoBioMed founded?
MiCoBioMed was founded in 2009.
Where is MiCoBioMed located?
MiCoBioMed is headquartered in Anseong, South Korea. It is registered at Anseong, Gyeonggi, South Korea.
What does MiCoBioMed do?
MiCoBioMed was established in 2009 and is based in Anseong, South Korea. Operations focus on the biomedical sector, where glucose monitoring sensors, devices, and test strips are manufactured and distributed. Sensors utilizing Surface Plasmon Resonance for planar surfaces and Localized Surface Plasmon Resonance for nanoscale metallic structures are also developed, supporting applications in diagnostics and sensing technologies.
Who are the top competitors of MiCoBioMed?
What products or services does MiCoBioMed offer?
MiCoBioMed offers Veri-Q PCR 316, Veri-Q PREP M16, Veri-Q COVID-19 Ag Rapid Test, Veri-Q COVID-19 IgG/IgM Rapid Test, and 2 more products and services.
Is MiCoBioMed publicly traded?
Yes, MiCoBioMed is publicly traded on KRX under the ticker symbol 214610.
What is MiCoBioMed's ticker symbol?
The ticker symbol of MiCoBioMed is 214610 on KRX.